(Q44323781)

2 December 2017

title

Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index (English)

1 reference

2 December 2017

1 reference

5

Jaffer Ajani

1 reference

2 December 2017

Arthur Hung

1

1 reference

2 December 2017

Christopher Crane

2

1 reference

2 December 2017

Marc Delclos

3

1 reference

2 December 2017

Matthew Ballo

4

1 reference

2 December 2017

Edward Lin

6

1 reference

2 December 2017

Barry Feig

7

1 reference

2 December 2017

John Skibber

8

1 reference

2 December 2017

Nora Janjan

9

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

2 December 2017

1 reference

2 December 2017

volume

97

1 reference

2 December 2017

issue

5

1 reference

2 December 2017

page(s)

1195-1202

1 reference

Combined therapy for cancer of the anal canal: a preliminary report

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11161

7 January 2021

Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11161

7 January 2021

Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11161

7 January 2021

Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11161

7 January 2021

Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11161

7 January 2021

Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11161

7 January 2021

Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11161

7 January 2021

Chemoradiation therapy for anal cancer: radiation plus continuous infusion of 5-fluorouracil with or without cisplatin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11161

7 January 2021

Late complications of postoperative radiation therapy for cancer of the rectum and rectosigmoid.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11161

7 January 2021

Squamous cell carcinoma of the anal canal

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11161

7 January 2021

Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): an Eastern Cooperative Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11161

7 January 2021

Squamous cell carcinoma of the anus at one hospital from 1948 to 1984

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11161

7 January 2021

Assessment of long-term quality of life in patients with anal carcinomas treated by radiotherapy with or without chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11161

7 January 2021

The effect of treatment duration in the local control of cervix cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11161

7 January 2021

The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a patterns-of-care study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11161

7 January 2021

Dose-time considerations of head and neck squamous cell carcinomas treated with irradiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11161

7 January 2021

The hazard of accelerated tumor clonogen repopulation during radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11161

7 January 2021

Outcome analysis of HIV-positive patients with anal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11161

7 January 2021

High HIV seroprevalence associated with gonorrhea: New York City Department of Health, sexually transmitted disease clinics, 1990-1997

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11161

7 January 2021

The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11161

7 January 2021

30 Gy may be an adequate dose in patients with anal cancer treated with excisional biopsy followed by combined-modality therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11161

7 January 2021

Identifiers

DOI

10.1002/CNCR.11161

1 reference

2 December 2017

1 reference